Nomic is a pioneering biotechnology company dedicated to making proteomics accessible, scalable, and routine, with the ultimate goal of advancing human health. Founded at McGill University, Nomic has developed the innovative nELISA® platform, which provides high-throughput, quantitative, and affordable protein data at an unprecedented scale. With the launch of the Omni 1000, Nomic is breaking down barriers in the field of proteomics, making large-scale quantitative analysis available to scientists across various domains, including drug discovery and AI-enabled therapeutic development. The company has established partnerships with leading organizations in pharma, biotech, and academia, and has profiled over 500,000 samples. Backed by significant investment, Nomic is building a team of world-changers who are passionate about transforming the future of medicine through accessible proteomics.